Frazier Life Sciences IX, L.P. → Phathom Pharmaceuticals, Inc. PHAT

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 9.23

10,637,936 shares short · -8.8% vs prior

Other 13D/G Filings on Phathom Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2024-04-01	SC	TAKEDA PHARMACEUTICAL CO LTD	—	—	view →
2021-11-12	SC	TAKEDA PHARMACEUTICAL CO LTD	—	—	view →
2021-04-06	SC	TAKEDA PHARMACEUTICAL CO LTD	—	—	view →
2021-04-01	SC	TAKEDA PHARMACEUTICAL CO LTD	—	—	view →
2020-01-27	SC	TAKEDA PHARMACEUTICAL CO LTD	—	—	view →

Other Filings by Frazier Life Sciences IX, L.P.

Filed	Form	Issuer	Stake	Shares
2026-01-27	SCHEDULE	Mirum Pharmaceuticals, Inc. MIRM	6.80%	4,108,404	view →
2023-09-05	SC	Mirum Pharmaceuticals, Inc. MIRM	—	—	view →
2021-01-27	SC	Passage BIO, Inc. PASG	—	—	view →
2020-12-18	SC	Mirum Pharmaceuticals, Inc. MIRM	—	—	view →
2020-04-29	SC	Mirum Pharmaceuticals, Inc. MIRM	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →